Citi Research forecasts Square can grow its sales by 29 percent annually through 2019. » Read More
By: Dan Mangan
UnitedHealth denies allegations it gamed the nation's Medicare system for hundreds of millions of dollars. » Read More
By: John Melloy
Fundstrat says the Facebook, Amazon, Netflix and Google-parent Alphabet stocks basket now has a value of $1.3 trillion. » Read More
By: Evelyn Cheng
Kraft Heinz's proposed Unilever merger marks another consolidation effort in the food industry by 3G Capital and Warren Buffett's Berkshire Hathaway. » Read More
Jim Cramer called for bearish analysts that didn't back the Newell-Rubbermaid and Jarden merger to eat crow.
Jim Cramer compared the restaurant, retail and banking cohorts to where he thought they would be a year ago.
Tempur Sealy shares plunged more than 22 percent intraday Wednesday after the mattress maker handed in a disappointing full-year sales guidance.
UBS' John Hodulik, a top-rated analyst, downgraded AT&T to neutral from buy on Wednesday, reducing his 12-month price target by 7 percent to $43.
"Halftime Report" trader Jon Najarian bought Grupo Televisa for his CNBC PRO model portfolio.
BlackBerry jumped Wednesday after it posted earnings. The company also announced the departure of its CFO, James Yersh.
A flurry of Fed speakers, including the Fed chair, will keep markets busy Wednesday.
Nomura initiates coverage of Amazon with a buy rating.
The "Fast Money" traders looked for opportunities in consumer stocks after Nike's future orders disappointed Wall Street on Tuesday.
Mizuho just downgraded Twitter to underperform, citing extended valuations and skepticism over whether the social media company will be acquired.
Some of the names on the move ahead of the open.
Jim Cramer spoke with the CEO of Thor Industries following record sales of RVs on what could be steering growth.
Jim Cramer officially unveils his new acronym for red-hot growth stocks in the market.
Shares of Ligand Pharmaceuticals plunged 12 percent Tuesday after Amgen said its multiple myeloma drug, Kyprolis, did not outperform Takeda Pharmaceutical's Velcade in a late-stage study.
Steven DeSanctis, one of the most widely followed small-cap strategists on Wall Street, discusses his top investment themes in the space.
Credit Suisse downgrades J.M. Smucker, maker of Kibbles 'n Bits dog food and Milk-Bone treats, to neutral from outperform.
With the race for the White House tightening, markets could be in for a bumpy road ahead in the near term.
Shares of Avis Budget Group fell more than 8 percent on a volume spike, following comments made Tuesday about weaker European demand in August.
Investors are unusually nervous about the market right now, which is "one more reason we're bullish on equities," says Oppenheimer's Ari Wald.
Rice Energy shares slid by more than 7 percent after buying Vantage Energy for about $2.7 billion, including debt.
Get the best of CNBC in your inbox